FDA Adverse Event Malfunction Summary report: N

BECKMAN TOTAL BILIRUBIN TRIGGERED (TB-T) KIT

MDR report key: 4735150 · Received April 28, 2015

Report

Report Number
2050010-2015-00001
Event Type
Malfunction
Date Received
April 28, 2015
Date of Event
April 1, 2015
Report Date
April 2, 2015
Manufacturer
BECKMAN COULTER
Product Code
CIG
PMA / PMN Number
K902801
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

.

Additional Manufacturer Narrative · 1

THE REAGENT WAS NOT RETURNED FOR EVALUATION. A BECKMAN COULTER (BEC) FIELD SERVICE ENGINEER WAS NOT DISPATCHED. THE SAMPLE WAS TESTED ON THE AU5800 CLINICAL CHEMISTRY SYSTEM, WHICH GENERATED BELIEVABLE RESULTS. BECKMAN (BEC) CHEMISTRY TECHNICAL APPLICATIONS REVIEWED THE CUSTOMER'S DATA AND FOUND EVIDENCE OF AN UNIDENTIFIED INTERFERENT PRESENT IN THE SAMPLE. INITIAL REPORTER'S TELEPHONE NUMBER:(B)(6).

Description of Event or Problem · 1

THE CUSTOMER REPORTED A FALSE LOW RESULT WAS GENERATED FROM THE BECKMAN TOTAL BILIRUBIN TRIGGERED (TB-T) (ALSO KNOWN AS TBIL) REAGENT KIT WHEN USED ON THE UNICEL DXC 800 PRO SYNCHRON SYSTEM. THE RESULT WAS QUESTIONED BECAUSE IT WAS LOWER THAN THE DIRECT BILIRUBIN (DBIL) RESULT FROM THE SAME SAMPLE. THE SAMPLE WAS RERUN ON A DIFFERENT DXC 800 PRO SYNCHRON SYSTEM WITH SIMILAR RESULTS. THERE WAS NO IMPACT TO PATIENT TREATMENT. THE RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. CONTROLS (QC) WERE RUN BEFORE AND AFTER THIS EVENT AND THE RESULTS WERE WITHIN RANGES. NO OTHER SAMPLES WERE AFFECTED. THE SAMPLE WAS TESTED ON THE AU5800 CLINICAL CHEMISTRY ANALYZER WHICH GENERATED BELIEVABLE RESULTS. THE DBIL RESULT WAS BELIEVED TO BE ERRONEOUS AS WELL, PLEASE REFER TO MDR 2050010-2015-00002 FOR THE EVENT RELATED TO DBIL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
278004 BECKMAN TOTAL BILIRUBIN TRIGGERED (TB-T) KIT DIAZO COLORIMETRY, BILIRUBIN CIG BECKMAN COULTER NA M407248

Patients

Seq Age Sex Outcome Treatment
1 49 YR